Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review.

[1]  A. Abulsoud,et al.  The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy. , 2023, Pathology, research and practice.

[2]  Abdallah Mansour,et al.  Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. , 2023, Pathology, research and practice.

[3]  Sherine M Rizk,et al.  Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of β-catenin protein level. , 2023, Non-coding RNA research.

[4]  Aimin Li,et al.  METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer , 2023, Cell Death & Disease.

[5]  T. Motawi,et al.  Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson's Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy. , 2022, ACS chemical neuroscience.

[6]  Yijin Chen,et al.  ALDH2 gene rs671 G > a polymorphism and the risk of colorectal cancer: A hospital‐based study , 2022, Journal of clinical laboratory analysis.

[7]  X. Tong,et al.  Sirtuin5 protects colorectal cancer from DNA damage by keeping nucleotide availability , 2022, Nature Communications.

[8]  N. Normanno,et al.  Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Amber N. Habowski,et al.  Disruption of the circadian clock drives Apc loss of heterozygosity to accelerate colorectal cancer , 2022, Science advances.

[10]  Lin Zheng,et al.  LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1 , 2022, EMBO reports.

[11]  A. A. Ahmed,et al.  miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review. , 2022, International journal of biological macromolecules.

[12]  Xinhui Wu,et al.  Risk of Colorectal Cancer in Patients With Irritable Bowel Syndrome: A Meta-Analysis of Population-Based Observational Studies , 2022, Frontiers in Medicine.

[13]  M. Abulsoud,et al.  Genetic impact of vitamin D receptor TaqI polymorphism on the risk of osteoporotic fractures in diabetic patients , 2022, Gene Reports.

[14]  B. Evers,et al.  Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells. , 2022, Molecular cancer therapeutics.

[15]  Jian Liang,et al.  Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis , 2022, Experimental and therapeutic medicine.

[16]  A. Parikh,et al.  The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer , 2022, PloS one.

[17]  S. Rudzki,et al.  Title: Risk Factors for the Diagnosis of Colorectal Cancer , 2022, Cancer control : journal of the Moffitt Cancer Center.

[18]  Wei-Chung Chiang,et al.  Mitophagy in aging and longevity , 2021, IUBMB life.

[19]  B. Zhivotovsky,et al.  Mitophagy in carcinogenesis and cancer treatment , 2021, Discover Oncology.

[20]  R. Urquhart,et al.  Socioeconomic inequalities in colorectal cancer incidence in Canada: trends over two decades , 2021, Cancer Causes & Control.

[21]  Lin Feng,et al.  Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis , 2021, Digestive Diseases and Sciences.

[22]  L. Mele,et al.  Colorectal Cancer Apoptosis Induced by Dietary δ-Valerobetaine Involves PINK1/Parkin Dependent-Mitophagy and SIRT3 , 2021, International journal of molecular sciences.

[23]  M. Du,et al.  Trends in Early-Onset vs. Late-Onset Colorectal Cancer Incidence by Race/Ethnicity in the US Cancer Statistics Database. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  Pengfei Xu,et al.  Global colorectal cancer burden in 2020 and projections to 2040 , 2021, Translational oncology.

[25]  T. Nagayasu,et al.  Colorectal cancer in Crohn’s disease: a series of 6 cases , 2021, Surgical Case Reports.

[26]  O. Shaker,et al.  Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition , 2021, International journal of molecular sciences.

[27]  Jiaxin Zhang,et al.  The Role of Mitophagy in Regulating Cell Death , 2021, Oxidative medicine and cellular longevity.

[28]  Dandan Wu,et al.  Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production , 2021, Cell Death & Differentiation.

[29]  E. Want,et al.  Lipid profiling of mouse intestinal organoids for studying APC mutations , 2021, Bioscience reports.

[30]  You Yang,et al.  Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin , 2021, Acta Pharmacologica Sinica.

[31]  Jinglan Zhang,et al.  PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades , 2021, Aging.

[32]  H. Weiss,et al.  Regulation of SIRT2 by Wnt/β-catenin signaling pathway in colorectal cancer cells. , 2021, Biochimica et biophysica acta. Molecular cell research.

[33]  F. Alcaín,et al.  SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases , 2021, Frontiers in Pharmacology.

[34]  S. Barry,et al.  The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer , 2021, Nature Genetics.

[35]  Ying Cui,et al.  SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/Cyclin D1 pathway. , 2020, Carcinogenesis.

[36]  He He,et al.  OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development , 2020, EMBO reports.

[37]  K. Das,et al.  Structure, mechanism, and regulation of mitochondrial DNA transcription initiation , 2020, The Journal of Biological Chemistry.

[38]  Jinfang Zhang,et al.  Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission , 2020, Molecular oncology.

[39]  Iekhsan Othman,et al.  Insights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism , 2020, Cancers.

[40]  E. Arbely,et al.  Cisplatin inhibits SIRT3-deacetylation MTHFD2 to disturb cellular redox balance in colorectal cancer cell , 2020, Cell Death & Disease.

[41]  R. Labianca,et al.  Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  D. Lai,et al.  The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells. , 2020, Oncology letters.

[43]  A. Avan,et al.  The genetic factors associated with Wnt signaling pathway in colorectal cancer. , 2020, Life sciences.

[44]  J. Xing,et al.  MCU-induced mitochondrial calcium uptake promotes mitochondrial biogenesis and colorectal cancer growth , 2020, Signal Transduction and Targeted Therapy.

[45]  P. Jiang,et al.  p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival , 2020, Nature Communications.

[46]  Jianyuan Luo,et al.  Citrate synthase desuccinylation by SIRT5 promotes colon cancer cell proliferation and migration , 2020, Biological chemistry.

[47]  Heshui Wu,et al.  Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway , 2020, Molecular therapy oncolytics.

[48]  T. Xia,et al.  SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of resveratrol , 2020 .

[49]  Wei Zhang,et al.  SIRT2‐dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases , 2020, EMBO reports.

[50]  M. Fassan,et al.  miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer , 2020, British Journal of Cancer.

[51]  E. Gharib,et al.  miR‐497‐5p mediates starvation‐induced death in colon cancer cells by targeting acyl‐CoA synthetase‐5 and modulation of lipid metabolism , 2020, Journal of cellular physiology.

[52]  Zhi-Pan Hong,et al.  miR-4999-5p Predicts Colorectal Cancer Survival Outcome and Reprograms Glucose Metabolism by Targeting PRKAA2 , 2020, OncoTargets and therapy.

[53]  C. Sebastián,et al.  Metabolic pathways regulating colorectal cancer initiation and progression. , 2020, Seminars in cell & developmental biology.

[54]  D. Chan.  Mitochondrial Dynamics and Its Involvement in Disease. , 2020, Annual review of pathology.

[55]  A. Jaśkiewicz,et al.  2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents , 2019, International journal of molecular sciences.

[56]  Dan Wang,et al.  Positiveregulationofhuman PINK1 and Parkin gene expression by Nuclear respiratory factor 1. , 2019, Mitochondrion.

[57]  Lingyun Yu,et al.  SSBP1 Upregulation In Colorectal Cancer Regulates Mitochondrial Mass , 2019, Cancer management and research.

[58]  Jianping Chen,et al.  Mitochondrial NOS1 suppresses apoptosis in colon cancer cells through increasing SIRT3 activity. , 2019, Biochemical and biophysical research communications.

[59]  Miao Sun,et al.  MiR-519b-3p Inhibits the Proliferation and Invasion in Colorectal Cancer via Modulating the uMtCK/Wnt Signaling Pathway , 2019, Front. Pharmacol..

[60]  P. Pizzo,et al.  Calcium, mitochondria and cell metabolism: A functional triangle in bioenergetics. , 2019, Biochimica et biophysica acta. Molecular cell research.

[61]  E. Riboli,et al.  Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[62]  S. Scholpp,et al.  Mechanisms of intercellular Wnt transport , 2019, Development.

[63]  S. Fedewa,et al.  Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening , 2019, CA: a cancer journal for clinicians.

[64]  C. Yun,et al.  PGC-1α Controls Mitochondrial Biogenesis in Drug-Resistant Colorectal Cancer Cells by Regulating Endoplasmic Reticulum Stress , 2019, International journal of molecular sciences.

[65]  Prashanth Rawla,et al.  Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors , 2019, Przeglad gastroenterologiczny.

[66]  Yibing Chen,et al.  Upregulation of mtSSB by interleukin‐6 promotes cell growth through mitochondrial biogenesis‐mediated telomerase activation in colorectal cancer , 2018, International journal of cancer.

[67]  S. Guraya.  The Prevalence and Evolving Risk Factors for Colorectal Cancer in the Arab World , 2018, Biomedical and Pharmacology Journal.

[68]  Hui Gao,et al.  MicroRNA‐23a promotes colorectal cancer cell survival by targeting PDK4 , 2018, Experimental cell research.

[69]  S. Quake,et al.  Single-nucleotide-resolution sequencing of human N6-methyldeoxyadenosine reveals strand-asymmetric clusters associated with SSBP1 on the mitochondrial genome , 2018, Nucleic acids research.

[70]  Jun Zheng,et al.  Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis , 2018, Nature Communications.

[71]  S. Chiang,et al.  HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer , 2018, Cell Death & Disease.

[72]  K. Lemberg,et al.  We're Not “DON” Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine , 2018, Molecular Cancer Therapeutics.

[73]  Y. Zhan,et al.  Down-Regulation of MicroRNA-214 Contributed to the Enhanced Mitochondrial Transcription Factor A and Inhibited Proliferation of Colorectal Cancer Cells , 2018, Cellular Physiology and Biochemistry.

[74]  Nektarios Tavernarakis,et al.  Mechanisms of mitophagy in cellular homeostasis, physiology and pathology , 2018, Nature Cell Biology.

[75]  Kathleen A. Boyle,et al.  Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation , 2018, The Journal of Biological Chemistry.

[76]  K. Vousden,et al.  Control of metabolism by p53 – Cancer and beyond , 2018, Biochimica et biophysica acta. Reviews on cancer.

[77]  Ignacio S. Caballero,et al.  Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells , 2018, PloS one.

[78]  You Wang,et al.  Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[79]  H. Moseley,et al.  Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer , 2018, Oncotarget.

[80]  M. Roh,et al.  Peroxisome proliferator-activated receptor γ coactivator-1α is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer. , 2018, Annals of diagnostic pathology.

[81]  Yibing Chen,et al.  Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer , 2018, Signal Transduction and Targeted Therapy.

[82]  Jie Xu,et al.  Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner , 2018, Nature Communications.

[83]  J. Yun,et al.  Downregulation of Drp1, a fission regulator, is associated with human lung and colon cancers , 2018, Acta biochimica et biophysica Sinica.

[84]  Zhe Wang,et al.  SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation. , 2018, Cancer research.

[85]  F. Ji,et al.  Synergistically suppressive effects on colorectal cancer cells by combination of mTOR inhibitor and glycolysis inhibitor, Oxamate. , 2018, International journal of clinical and experimental pathology.

[86]  He-dong Lang,et al.  Crosstalk between gut microbiota and Sirtuin-3 in colonic inflammation and tumorigenesis , 2018, Experimental & Molecular Medicine.

[87]  W. Frankel,et al.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting , 2018, Cancer and Metastasis Reviews.

[88]  Joo-In Park,et al.  Expression of fatty acid synthase is regulated by PGC‑1α and contributes to increased cell proliferation. , 2017, Oncology reports.

[89]  T. Fernández-Villa,et al.  Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review , 2017, BMC Cancer.

[90]  J. Herranz,et al.  Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role[S] , 2017, Journal of Lipid Research.

[91]  Lin Chen,et al.  Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer. , 2017, Oncology letters.

[92]  Peng Shu,et al.  miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[93]  Nuno A. Fonseca,et al.  Comprehensive molecular characterization of mitochondrial genomes in human cancers , 2017, bioRxiv.

[94]  S. Su,et al.  Isocitrate Dehydrogenase Mutation and (R)-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development. , 2017, Annual review of biochemistry.

[95]  Y. Sakai,et al.  Targeting metabolic reprogramming in KRAS-driven cancers , 2017, International Journal of Clinical Oncology.

[96]  Jin Han,et al.  Mitochondrial Nucleoid: Shield and Switch of the Mitochondrial Genome , 2017, Oxidative medicine and cellular longevity.

[97]  L. Cantley,et al.  Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin. , 2017, Cell reports.

[98]  David A. Drew,et al.  Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes. , 2017, Gastroenterology.

[99]  S. Park,et al.  Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy. , 2017, Antioxidants & redox signaling.

[100]  Nektarios Tavernarakis,et al.  Mitochondrial biogenesis and clearance: a balancing act , 2017, The FEBS journal.

[101]  J. Chipuk,et al.  Mitochondrial dynamics as regulators of cancer biology , 2017, Cellular and Molecular Life Sciences.

[102]  Suguru Hasegawa,et al.  Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase12 , 2016, Neoplasia.

[103]  M. Lazarou,et al.  Deciphering the Molecular Signals of PINK1/Parkin Mitophagy. , 2016, Trends in cell biology.

[104]  K. Schmid,et al.  Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status , 2016, World Journal of Surgical Oncology.

[105]  Navdeep S. Chandel,et al.  Fundamentals of cancer metabolism , 2016, Science Advances.

[106]  A. Bode,et al.  The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications , 2016, Molecular Cancer Therapeutics.

[107]  M. Pal,et al.  Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue , 2016, Tumor Biology.

[108]  Lewis C Cantley,et al.  Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer. , 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[109]  Jinhang Gao,et al.  De-methylation of displacement loop of mitochondrial DNA is associated with increased mitochondrial copy number and nicotinamide adenine dinucleotide subunit 2 expression in colorectal cancer. , 2015, Molecular medicine reports.

[110]  Richa Saxena,et al.  Association of Genes, Pathways, and Haplogroups of the Mitochondrial Genome with the Risk of Colorectal Cancer: The Multiethnic Cohort , 2015, PloS one.

[111]  Ge Zhang,et al.  Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism , 2015, Oncotarget.

[112]  K. Linask,et al.  The cAMP phosphodiesterase Prune localizes to the mitochondrial matrix and promotes mtDNA replication by stabilizing TFAM , 2015, EMBO reports.

[113]  Y. Kitagishi,et al.  Functions and characteristics of PINK1 and Parkin in cancer. , 2015, Frontiers in bioscience.

[114]  X. Shu,et al.  Association of Leukocyte Mitochondrial DNA Copy Number with Colorectal Cancer Risk: Results from the Shanghai Women's Health Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[115]  C. Thompson,et al.  Wnt meets Warburg: another piece in the puzzle? , 2014, The EMBO journal.

[116]  E. Gratton,et al.  Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer , 2014, The EMBO journal.

[117]  R. Salgia,et al.  Mitochondrial dynamics: biology and therapy in lung cancer , 2014, Expert opinion on investigational drugs.

[118]  Mong-Hong Lee,et al.  Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies , 2014, Cancer biology & medicine.

[119]  Haichao Wang,et al.  The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics , 2014, Oncogene.

[120]  A. Levine,et al.  Tumor-Associated Mutant p53 Drives the Warburg Effect , 2013, Nature Communications.

[121]  A. Hoeflich,et al.  Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. , 2013, Mitochondrion.

[122]  Alexander M van der Bliek,et al.  Mechanisms of mitochondrial fission and fusion. , 2013, Cold Spring Harbor perspectives in biology.

[123]  P. Chinnery,et al.  Mitochondrial genetics , 2013, British medical bulletin.

[124]  Huangxian Ju,et al.  MicroRNA: function, detection, and bioanalysis. , 2013, Chemical reviews.

[125]  Gregory Stephanopoulos,et al.  The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4 , 2013, Cell.

[126]  Xiaoling Xu,et al.  SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. , 2013, Cancer cell.

[127]  Constance M. Johnson,et al.  Meta-analyses of colorectal cancer risk factors , 2013, Cancer Causes & Control.

[128]  Ge Zhang,et al.  Epithelial–Mesenchymal Transition (EMT) Induced by TNF-α Requires AKT/GSK-3β-Mediated Stabilization of Snail in Colorectal Cancer , 2013, PloS one.

[129]  W. Gu,et al.  p53-dependent regulation of metabolic function through transcriptional activation of pantothenate kinase-1 gene , 2013, Cell cycle.

[130]  D. Temiakov,et al.  Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. , 2013, Molecular cell.

[131]  Juan Zhang,et al.  Mitochondrial dynamics regulates migration and invasion of breast cancer cells , 2012, Oncogene.

[132]  X. Cheng,et al.  Cell-cycle arrest at G2/M and proliferation inhibition by adenovirus-expressed mitofusin-2 gene in human colorectal cancer cell lines. , 2013, Neoplasma.

[133]  Jianping Zhou,et al.  Knockdown of p62/sequestosome 1 attenuates autophagy and inhibits colorectal cancer cell growth , 2013, Molecular and Cellular Biochemistry.

[134]  R. Sinha,et al.  Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. , 2012, Journal of the National Cancer Institute.

[135]  J. Kolesar,et al.  Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. , 2012, Biochimica et biophysica acta.

[136]  D. Bogenhagen.  Mitochondrial DNA nucleoid structure. , 2012, Biochimica et biophysica acta.

[137]  Y. Matsushima,et al.  Matrix proteases in mitochondrial DNA function. , 2012, Biochimica et biophysica acta.

[138]  Wei Cheng,et al.  Correlation between increased ND2 expression and demethylated displacement loop of mtDNA in colorectal cancer. , 2012, Molecular medicine reports.

[139]  H. Oda,et al.  Depletion of mitochondrial fission factor DRP1 causes increased apoptosis in human colon cancer cells. , 2012, Biochemical and biophysical research communications.

[140]  David S. Park,et al.  Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment , 2012, EMBO reports.

[141]  K. Hemminki,et al.  Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. , 2012, Mutagenesis.

[142]  J. Hampe,et al.  Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer , 2012, BMC Medical Genetics.

[143]  P. Puigserver,et al.  PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. , 2011, Cancer research.

[144]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[145]  A. Moschetta,et al.  Bax is necessary for PGC1α pro-apoptotic effect in colorectal cancer cells , 2011, Cell cycle.

[146]  Wei Cheng,et al.  Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancer. , 2011, Oncology letters.

[147]  J. Carethers.  One colon lumen but two organs. , 2011, Gastroenterology.

[148]  A. Vaiopoulou,et al.  Polymorphisms of Caspase 8 and Caspase 9 gene and colorectal cancer susceptibility and prognosis , 2011, International Journal of Colorectal Disease.

[149]  Cole M. Haynes,et al.  Mitochondrial protein quality control during biogenesis and aging. , 2011, Trends in biochemical sciences.

[150]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[151]  Dongchon Kang,et al.  Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer. , 2011, Cancer research.

[152]  C. Lelliott,et al.  Peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC1α) is a metabolic regulator of intestinal epithelial cell fate , 2011, Proceedings of the National Academy of Sciences.

[153]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[154]  C. Croce,et al.  microRNAs: Master regulators as potential therapeutics in cancer. , 2011, Annual review of pharmacology and toxicology.

[155]  M. Houshmand,et al.  Analysis of mitochondrial ND1 gene in human colorectal cancer , 2011, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[156]  T. Oda,et al.  Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice , 2010, Cancer science.

[157]  P. Huang,et al.  Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression , 2010, Oncogene.

[158]  R. Wong.  Proximal Tumors Are Associated with Greater Mortality in Colon Cancer , 2010, Journal of General Internal Medicine.

[159]  Borivoj Vojnovic,et al.  MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU , 2010, PloS one.

[160]  D. Sinclair,et al.  Mammalian sirtuins: biological insights and disease relevance. , 2010, Annual review of pathology.

[161]  M. Houshmand,et al.  High Rate of Mutation in Mitochondrial DNA Displacement Loop Region in Human Colorectal Cancer , 2009, Diseases of the colon and rectum.

[162]  C. Deng,et al.  SIRT3 interacts with the daf-16 homolog FOXO3a in the Mitochondria, as well as increases FOXO3a Dependent Gene expression , 2008, International journal of biological sciences.

[163]  N. Hamasaki,et al.  Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. , 2007, Mitochondrion.

[164]  F. Alt,et al.  SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells , 2006, Cell.

[165]  Bin Zhang,et al.  Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation. , 2005, Biochemical and biophysical research communications.

[166]  Pen-Hui Yin,et al.  Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers , 2005, Annals of the New York Academy of Sciences.

[167]  Yau-Huei Wei,et al.  Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. , 2005, The international journal of biochemistry & cell biology.

[168]  Rodrigue Rossignol,et al.  Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells , 2004, Cancer Research.

[169]  J. Woodgett,et al.  Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. , 2002, Advances in cancer research.

[170]  W. H. Lewis,et al.  Mitochondria (and other cytoplasmic structures) in tissue cultures , 1915 .